Navigation Links
The Risks Involved In Purchase Of Over The Counter Medications

According to a latest study researchers say health professionals and patients require education programmes in // order effectively manage the risks associated with over the counter drugs. Of the many conditions treated , a headache is one of the most common condition that people choose to treat by themselves by purchasing Over-the-Counter Medications. Some of the other commonly treated ailments include heartburn, migraine, period pain, coughs, colds, and acid stomach.

The report also indicates that the trend towards greater self-treatment is indeed a sensible use of resources however if misused it could be dangerous. Drugs freely available over the counter are also at risk of being overused. Doctors are of the opinion that there is a need to increase education of health professionals and patients so that they would be able to keep pace with the increased availability of drugs over the counter. They also add that it is of great importance that the public realize that just because medicines are available over the counter it does not mean that they are risk-free, hence they say that educational programmes and improved labeling could help people understand how to make the best use of over the counter medicines and thus take control of their illness more effectively. Researchers of the study also suggest that the distribution of a general leaflet made available in pharmacies, describing the trend in over the counter availability and the advantages and disadvantages of over the counter medication might encourage patients to report adverse reactions.
'"/>




Page: 1

Related medicine news :

1. Simvastatin Plus Niacin May Lower Heart Risks
2. Risks for Silent Strokes
3. Ginseng Associated with Pregnancy Risks
4. Benefits and Risks of Asthma Treatment Questioned
5. Lack of Smell And Its Potential Risks
6. A Slight Increase In BP Can Mean big Risks
7. The Risks Of Smoking
8. Risks Of An Enlarged Heart
9. Identifying The Risks Of Developing Schizophrenia
10. Evaluating The Risks and Benefits of Hormone Therapy
11. The Risks Of Vitamin D Deficiency
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... extensive sequencing and genomics experience, as Vice President of North American Capital Sales at ... responsible for leading the sales team in the commercialization of the HTG EdgeSeq system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: